학술논문
Fraisinib: a calixpyrrole derivative reducing A549 cell-derived NSCLC tumor in vivo acts as a ligand of the glycine-tRNA synthase, a new molecular target in oncology
Document Type
Article
Author
Ben Toumia, I.; Bachetti, T.; Profumo, A.; Ponassi, M.; Izzotti, A.; Tkachenko, K.; Cardinali, B.; Romano, P.; Iervasi, E.; Vargas, G.C.; Barboro, P.; Rosano, C.; Chekir-Ghedira, L.; Di Domizio, A.; Fiordoro, S.; Drago, G.; Sciacca, S.; Puglisi, C.; Forte, S.; Giuffrida, R.; Colarossi, C.; Milardi, D.; Lanza, V.; Grasso, G.; Kohnke, F.H.
Source
In: Frontiers in Pharmacology . (Frontiers in Pharmacology, 2023, 14)
Subject
Language
English
ISSN
16639812